GUARD Statistics

Total Valuation

Guard Therapeutics International AB has a market cap or net worth of SEK 248.36 million. The enterprise value is 181.58 million.

Market Cap	248.36M
Enterprise Value	181.58M

Important Dates

The last earnings date was Friday, November 8, 2024.

Earnings Date	Nov 8, 2024
Ex-Dividend Date	n/a

Share Statistics

Guard Therapeutics International AB has 12.29 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	12.29M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	16.03%
Owned by Institutions (%)	30.26%
Float	8.73M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.08
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.26

Current Ratio	6.26
Quick Ratio	5.58
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-66.42

Financial Efficiency

Return on equity (ROE) is -119.12% and return on invested capital (ROIC) is -75.53%.

Return on Equity (ROE)	-119.12%
Return on Assets (ROA)	-61.32%
Return on Capital (ROIC)	-75.53%
Revenue Per Employee	n/a
Profits Per Employee	-7.93M
Employee Count	11
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.11% in the last 52 weeks. The beta is -0.08, so Guard Therapeutics International AB's price volatility has been lower than the market average.

Beta (5Y)	-0.08
52-Week Price Change	-28.11%
50-Day Moving Average	24.96
200-Day Moving Average	26.62
Relative Strength Index (RSI)	31.48
Average Volume (20 Days)	4,509

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-88.47M
Pretax Income	-87.20M
Net Income	-87.20M
EBITDA	-88.45M
EBIT	-88.47M
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	66.78M
Total Debt	n/a
Net Cash	66.78M
Net Cash Per Share	5.43
Equity (Book Value)	63.29M
Book Value Per Share	n/a
Working Capital	63.50M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-91.56M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Guard Therapeutics International AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on December 15, 2023. It was a reverse split with a ratio of 0.02.

Last Split Date	Dec 15, 2023
Split Type	Reverse
Split Ratio	0.02

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a